# Iatrogenically Acquired Mycobacterium abscessus Infection in an Indwelling Intercostal Drainage In Situ in a Patient With Alcoholic Liver Disease and Bilateral Hepatic Hydrothorax: A Report of a Rare Case

**Authors:** Rahul Ranjan, Jayanthi Gunasekaran, Raunak Bir, Umesh Kumar, Rajiv M Gupta

PMC · DOI: 10.7759/cureus.59626 · Cureus · 2024-05-04

## TL;DR

A patient with liver disease developed a rare Mycobacterium abscessus infection from an indwelling drainage catheter, which was identified after months of diagnostic uncertainty.

## Contribution

This case report highlights the rare occurrence of iatrogenic Mycobacterium abscessus infection associated with an indwelling intercostal drainage catheter.

## Key findings

- Mycobacterium abscessus subsp. abscessus was isolated from pleural fluid after prolonged diagnostic investigation.
- The infection was resistant to macrolides but sensitive to aminoglycosides.
- The patient was treated with a combination of amikacin, tigecycline, and imipenem.

## Abstract

A 47-year-old male, a known case of alcoholic chronic liver disease with portal hypertension, presented with complaints of abdominal distension and shortness of breath. A provisional diagnosis of ethanol-related compensated chronic liver disease (CLD) with portal hypertension and splenomegaly, gross ascites with bilateral hepatic hydrothorax was made. The left-sided pleural effusion subsided after three pleural taps, but the right-sided effusion kept refilling even after four to five days of repeated therapeutic taps, so a pigtail catheter was left in situ. The pleural fluid was sent for culture which did not grow any pathogenic organisms. Cartridge-based nucleic acid amplification tests where Mycobacterium tuberculosis complex (MTBC) was not detected, Ziehl-Neelsen staining was done in which acid-fast bacilli were not seen, and cytology was done where no malignant cells were seen. The patient was discharged with the pigtail in situ on the right side and, after 20 days, the patient again presented with shortness of breath, and imaging revealed moderate right-side pleural effusion. Draining of pleural fluid was done and sent for investigation which again revealed no infective etiology. The patient was admitted to the hospital for one month as the right-sided effusion did not resolve. Suddenly, the patient developed shortness of breath, and a chest X-ray was done, which showed pigtail blockage; pigtail flushing was done, and the bag was drained. The patient was empirically started on IV meropenem 500 mg TID, IV teicoplanin 400 mg BD, and inj polymyxin B 500,000 IU IV BD. The pleural fluid was sent continuously for investigation for the first two months which again did not reveal any infective etiology. After two months of pigtail in situ, the pleural fluid was sent for CBNAAT where MTBC was not detected, and ZN stain showed smooth acid-fast bacilli. The sample was cultured, and it grew acid-fast bacilli in 72 hours on blood agar, MacConkey agar, and Lowenstein-Jensen media. A line probe assay done from the isolate revealed it to be Mycobacterium abscessus subsp. abscessus which was resistant to macrolides and sensitive to aminoglycosides. Mycobacterium abscessus subsp. abscessus was isolated from repeated cultures of pleural fluid, and the patient was advised on a combination treatment of amikacin, tigecycline, and imipenem. The patient was discharged with the indwelling pigtail with the advised treatment; unfortunately, we lost patient follow-up as the patient never returned to us.

## Linked entities

- **Chemicals:** meropenem (PubChem CID 441130), teicoplanin (PubChem CID 133065662), amikacin (PubChem CID 37768), tigecycline (PubChem CID 54686904), imipenem (PubChem CID 104838)
- **Diseases:** portal hypertension (MONDO:0005080)

## Full-text entities

- **Diseases:** portal hypertension (MESH:D006975), Hepatic Hydrothorax (MESH:D006876), pleural effusion (MESH:D010996), ascites (MESH:D001201), abdominal distension (MESH:D000007), Mycobacterium abscessus Infection (MESH:D009165), effusion (MESH:D000080324), CLD (MESH:D008107), Alcoholic Liver Disease (MESH:D008108), splenomegaly (MESH:D013163), shortness of breath (MESH:D004417)
- **Chemicals:** imipenem (MESH:D015378), aminoglycosides (MESH:D000617), ethanol (MESH:D000431), amikacin (MESH:D000583), macrolides (MESH:D018942), teicoplanin (MESH:D017334), -Neelsen (-), ZN (MESH:D015032), meropenem (MESH:D000077731), tigecycline (MESH:D000078304)
- **Species:** Mycobacterium tuberculosis complex (species group) [taxon 77643], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11145738/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11145738/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC11145738/full.md

---
Source: https://tomesphere.com/paper/PMC11145738